Clinical Mass Spectrometry Market World's Top Players Include Agilent Technologies , Waters, Shimadzu Corporation, Danaher, PerkinElmer Inc.

The global clinical mass spectrometry market is estimated to be valued at US$ 4,982.5 million in 2017 and is expected to witness a CAGR of 7.3% over the forecast period (2017 – 2025).Clinical mass spectrometry serves as a quantitative and qualitative analytical tool for assessment of complex mixtures in all the phases of drug development, including identification of the lead compound and their conformational details. Clinical laboratories use automation for the management of large number of samples through, either total automation systems or high level analyzer automation that are offered by clinical mass spectrometers such as Matrix Assisted Laser Desorption/Ionization (MALDI-TOF).

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/193

Clinical diagnostic mass spectrometers have the capacity to analyze a limited range of samples such as biomarkers, proteins or drug molecules at once, even in cases of low concentrations thus, making them a valuable tool for diagnostic medical laboratories. Furthermore, it allows researchers to determine pharmacokinetic profiles of drugs that are administered in microdoses.

Increasing demand for automation in diagnostic techniques to drive growth of the clinical mass spectrometry market

Mass spectrometry enables various diagnostic analyses and study of functional genomics, metabolomics, and proteomics that facilitate development of a cost-effective analytic platform for analysis of samples. The automated laboratory systems provide several high-end functionalities such as MassEXTEND primer extension and nano liter dispensing of samples on to the spectroCHIPS, and data analysis using pre-loaded workstations that make the task of the clinicians and testing personnel easy and less tedious.

Technological advancements leading to new product launch is a prominent factor fueling growth of the clinical mass spectrometry market

Advancements in technology includes miniaturization of mass spectrometry
instruments and increasing automation of the entire spectrometric unit to reduce human efforts and improve efficiency of the instruments.

North America held the maximum share of clinical mass spectrometry market in 2016, owing to the presence of major key players and strategic collaborations. The second largest market share is provided by Europe. Under the Federation of analytical Chemistry and Spectrometry Societies, American Society for Mass Spectrometry was formed in 1969, with over 7,500 scientists working together to make advancements in the clinical applications of mass spectrometry and allied topics in academic, industrial, and governmental laboratories.

Key Companies

Key companies covered as part of this study include Agilent Technologies , Waters, Shimadzu Corporation, Danaher, PerkinElmer Inc., Thermo Fisher Scientific Inc., Bruker, Mass Spectrometry Instruments (MSI), and Kore technology

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/193

Detailed Segmentation:

• Global Clinical Mass Spectrometry Market, By Product Type:

o Gas chromatography–mass spectrometry-(GC MS) instrument
o Liquid chromatography–mass spectrometry-(LC MS) instrument
o Maldi TOF mass spectrometer
o Capillary electrophoresis–mass spectrometry
o Ion mobility spectrometry-mass spectrometry

• Global Clinical Mass Spectrometry Market, By Application:

o Clinical Testing
o Proteomics
o Drug Discovery

• Global Clinical Mass Spectrometry Market, By End User:

o Research Laboratories
o Diagnostic Laboratories
o Hospitals

• Global Clinical Mass Spectrometry Market, By Geography:

o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.